Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect

Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect

US Patent 9889088 · Granted Feb 13, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sterilization device utilizing low intensity UV-C radiation and ozone2023
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Presbyopia treatments2022
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, 2021
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, 2021
Sulfur derivatives as chemokine receptor modulators2021
Heavy chain only antibodies to ANG-22021
Heavy chain only antibodies to PDGF2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021